Nanobiotix SA (NBTX)
37.46
+0.82
(+2.24%)
USD |
NASDAQ |
Sep 10, 16:00
37.46
0.00 (0.00%)
After-Hours: 18:56
Nanobiotix Market Cap : 1.813B for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 1.773B |
| September 08, 2026 | 1.848B |
| September 04, 2026 | 1.877B |
| September 03, 2026 | 1.936B |
| September 02, 2026 | 2.016B |
| September 01, 2026 | 1.901B |
| August 31, 2026 | 1.966B |
| August 28, 2026 | 1.995B |
| August 27, 2026 | 2.185B |
| August 26, 2026 | 2.153B |
| August 25, 2026 | 2.009B |
| August 24, 2026 | 1.919B |
| August 21, 2026 | 2.107B |
| August 20, 2026 | 2.114B |
| August 19, 2026 | 2.196B |
| August 18, 2026 | 1.988B |
| August 17, 2026 | 2.035B |
| August 14, 2026 | 1.854B |
| August 13, 2026 | 1.847B |
| August 12, 2026 | 1.908B |
| August 11, 2026 | 1.874B |
| August 10, 2026 | 1.751B |
| August 07, 2026 | 1.849B |
| August 06, 2026 | 1.829B |
| August 05, 2026 | 1.920B |
| Date | Value |
|---|---|
| August 04, 2026 | 1.912B |
| August 03, 2026 | 1.882B |
| July 31, 2026 | 1.857B |
| July 30, 2026 | 1.943B |
| July 29, 2026 | 1.831B |
| July 28, 2026 | 1.830B |
| July 27, 2026 | 1.944B |
| July 24, 2026 | 1.921B |
| July 23, 2026 | 1.914B |
| July 22, 2026 | 1.954B |
| July 21, 2026 | 1.907B |
| July 20, 2026 | 1.729B |
| July 17, 2026 | 1.829B |
| July 16, 2026 | 1.816B |
| July 15, 2026 | 1.934B |
| July 14, 2026 | 2.015B |
| July 13, 2026 | 1.894B |
| July 10, 2026 | 1.939B |
| July 09, 2026 | 1.885B |
| July 08, 2026 | 1.877B |
| July 07, 2026 | 1.877B |
| July 06, 2026 | 1.989B |
| July 02, 2026 | 1.858B |
| July 01, 2026 | 1.910B |
| June 30, 2026 | 1.824B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nicox SA | 26.44M |
| DBV Technologies SA | 766.42M |
| Cellectis SA | 319.21M |
| Genfit SA | 787.82M |
| Innate Pharma SA | 177.09M |
Market Cap Related Metrics
| PS Ratio | 54.83 |
| Price | 37.46 |
| Earnings Yield | -1.53% |
| Normalized PE Ratio | 73.74 |